# Weighted Versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Knee Arthroplasty

> **NCT01651806** · PHASE2,PHASE3 · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 65 (actual)

## Conditions studied

- Osteoarthritis
- Intraoperative Bleeding

## Interventions

- **DRUG:** Tranexamic Acid standard dose
- **DRUG:** Females Tranexamic Acid weighted dose
- **DRUG:** Females receiving a uniform dose of TA
- **DRUG:** Males Weighted Dose TA

## Key facts

- **NCT ID:** NCT01651806
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651806, "Weighted Versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Knee Arthroplasty". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01651806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*